IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 194
Titolo Data di pubblicazione Autore(i) File
MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach 1-gen-2011 Martinelli, Erika; Troiani, Teresa; Morgillo, Floriana; Orditura, Michele; Capasso, A; D'Aiuto, E; Vecchione, L; DE PALMA, Raffaele; Ciardiello, Fortunato
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 1-gen-2011 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato; Ciardiello, F.
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors 1-gen-2011 Morgillo, Floriana; Cascone, T; D'Aiuto, E; Martinelli, Erika; Troiani, Teresa; Saintigny, P; DE PALMA, Raffaele; Heymach, Jv; Berrino, Liberato; Tuccillo, C; Ciardiello, Fortunato
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 1-gen-2011 Morgillo, Floriana; D'Aiuto, E; Troiani, Teresa; Martinelli, Erika; Cascone, T; DE PALMA, Raffaele; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 1-gen-2011 Orditura, Michele; Galizia, Gennaro; Morgillo, Floriana; Martinelli, Erika; Lieto, Eva; Vitiello, F; Di Martino, N; Pacelli, R; Renda, A; Ciardiello, Fortunato; DE VITA, Ferdinando
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 1-gen-2011 DE VITA, Ferdinando; Orditura, Michele; Martinelli, Erika; Vecchione, L; Innocenti, R; Sileni, Vc; Pinto, C; Di Maio, M; Farella, A; Troiani, Teresa; Morgillo, Floriana; Napolitano, Vincenzo; Ancona, E; Di Martino, N; Ruol, A; Galizia, Gennaro; Del Genio, A; Ciardiello, Fortunato
Combination therapy with anti-EGFR monoclonal antibodies in the treatment of NSCLC. 1-gen-2012 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
ROLE OF THE HEDGEHOG PATHWAY IN MEDIATING RESISTANCE TO ANTI-EGFR TYROSINE KINASE INHIBITORS IN NON SMALL CELL LUNG CANCER 1-gen-2012 Morgillo, Floriana; DELLA CORTE, Carminia Maria; Martini, G; Manzo, A; Gambardella, V; Vitagliano, D; Martinelli, Erika; Troiani, Teresa; Ciardiello, Fortunato
Targeting EGFR in Pancreatic Cancer Treatment. 1-gen-2012 Troiani, Teresa; Martinelli, Erika; Capasso, A; Morgillo, Floriana; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer. 1-gen-2012 Troiani, Teresa; Martinelli, Erika; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato; Morgillo, Floriana
CLINICAL RESULTS WITH EGFR INHIBITORS IN COLORECTAL CANCER 1-gen-2012 Martinelli, Erika; Troiani, Teresa; Morgillo, Floriana; Ciardiello, Fortunato
OPTIMIZING THERAPEUTIC COMBINATIONS OF A SELECTIVE MEK 1/2 INHIBITOR (PIMASERTIB) WITH PI3K/ MTOR INHIBITORS OR WITH MULTI-TARGETED KINASE INHIBITORS IN PIMASERTIB-RESISTANT HUMAN LUNG AND COLORECTAL CANCER CELLS 1-gen-2012 Martinelli, Erika; Troiani, Teresa; Morgillo, Floriana; D’Aiuto, E; Ciuffrida, L; Costantini, S; Vecchione, L; De Vriendt, V; Tejpar, S; Ciardiello, Fortunato
PHASE I/II STUDY OF FOLFIRI PLUS THE MEK1/2 INHIBITOR PIMASERTIB (MSC1936369B) AS SECOND-LINE TREATMENT FOR KRAS MUTATED METASTATIC COLORECTAL CANCER 1-gen-2012 Macarulla, T; Tabernero, J; Cervantes, A; Rosello, S; Van Cutsem, E; Tejpar, S; Prenen, H; Martinelli, Erika; Troiani, Teresa; Campana, F; Laffranchi, B; Jego, V; Von Richter, O; Ciardiello, Fortunato
MET ACTIVATION BY AUTOCRINE LOOP RESCUES COLON CANCER CELLS FROM SENSITIVITY TO EGFR INHIBITION 1-gen-2012 Troiani, Teresa; Vitagliano, D; Napolitano, S; Morgillo, Floriana; Capasso, A; Sforza, V; Nappi, A; Berrino, Liberato; Ciardiello, Fortunato; Martinelli, Erika
Using pharmacokinetic and pharmacodynamic data in early decision making regarding drug development: a phase I clinical trial evaluating tyrosine kinase inhibitor, AEE788. 1-gen-2012 Baselga, J; Mita, Ac; Schöffski, P; Dumez, H; Rojo, F; Tabernero, J; Dilea, C; Mietlowski, W; Low, C; Huang, J; Dugan, M; Parker, K; Walk, E; van Oosterom, A; Martinelli, Erika; Takimoto, C. h.
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells. 1-gen-2012 Troiani, Teresa; Vecchione, L; Martinelli, Erika; Capasso, A; Costantino, S; Ciuffreda, Lp; Morgillo, Floriana; Vitagliano, D; D'Aiuto, E; DE PALMA, Raffaele; Tejpar, S; Van Cutsem, E; De Lorenzi, M; Caraglia, Michele; Berrino, Liberato; Ciardiello, Fortunato
ONCOLOGIA MEDICA 1-gen-2013 Ciardiello, Fortunato; Orditura, Michele; DE VITA, Ferdinando; Diadema, Mr; Guasrafierro, S; Martinelli, Erika; Morgillo, Floriana; Troiani, Teresa
Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab? 1-gen-2013 Troiani, Teresa; Martinelli, Erika; Morgillo, Floriana; Capasso, A; Nappi, A; Sforza, V; Ciardiello, Fortunato
Metformin in lung cancer: rationale for a combination therapy 1-gen-2013 Morgillo, Floriana; Sasso, Ferdinando Carlo; Della Corte, Cm; Festino, L; Manzo, A; Martinelli, Erika; Troiani, Teresa; Capuano, Annalisa; Ciardiello, Fortunato
Critical appraisal of the use of regorafenib in the management of colorectal cancer. 1-gen-2013 Festino, L; Fabozzi, A; Manzo, A; Gambardella, V; Martinelli, Erika; Troiani, Teresa; DE VITA, Ferdinando; Orditura, Michele; Ciardiello, Fortunato; Morgillo, Floriana
Mostrati risultati da 41 a 60 di 194
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile